We are live on ! Find out more

1,031 hedge funds and large institutions have $20.9B invested in Labcorp in 2026 Q1 according to their latest regulatory filings, with 109 funds opening new positions, 336 increasing their positions, 374 reducing their positions, and 88 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $26.4M | Put options by funds: $11.4M

78% more funds holding in top 10

Funds holding in top 10: 916 (+7)

24% more first-time investments, than exits

New positions opened: 109 | Existing positions closed: 88

4% more capital invested

Capital invested by funds: $20B → $20.9B (+$818M)

1% more funds holding

Funds holding: 1,0241,031 (+7)

1.42% less ownership

Funds ownership: 96.4%94.98% (-1.4%)

10% less repeat investments, than reductions

Existing positions increased: 336 | Existing positions reduced: 374

Holders
1,031
Holders Change
+7
Holders Change %
+0.68%
% of All Funds
12.68%
Holding in Top 10
16
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+77.78%
% of All Funds
0.2%
New
109
Increased
336
Reduced
374
Closed
88
Calls
$26.4M
Puts
$11.4M
Net Calls
+$15M
Net Calls Change
+$40.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Thrivent Financial for Lutherans
26
Thrivent Financial for Lutherans
Minnesota
$187M +$33.7M +124,611 +22%
CB
27
Cooke & Bieler
Pennsylvania
$180M -$21.4M -78,895 -10%
Legal & General Group
28
Legal & General Group
United Kingdom
$179M -$760K -2,807 -0.4%
Charles Schwab
29
Charles Schwab
California
$172M +$1.51M +5,576 +0.9%
BMO
30
Beck Mack & Oliver
New York
$165M -$2.82M -10,406 -2%
Lord, Abbett & Co
31
Lord, Abbett & Co
New Jersey
$156M -$12.6M -46,418 -7%
Bessemer Group
32
Bessemer Group
New Jersey
$154M +$50.3M +185,847 +47%
UBS Group
33
UBS Group
Switzerland
$151M +$18.7M +68,994 +14%
Massachusetts Financial Services
34
Massachusetts Financial Services
Massachusetts
$148M -$4.53M -16,724 -3%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$143M -$10.2M -37,535 -7%
RRAM
36
River Road Asset Management
Kentucky
$135M +$26.2M +96,676 +24%
MAM
37
Madison Asset Management
Wisconsin
$131M -$9.57M -35,332 -7%
VFT
38
Vanguard Fiduciary Trust
Pennsylvania
$124M +$126M +466,547 New
WP
39
Woodline Partners
California
$119M +$11.3M +41,705 +10%
Natixis Advisors
40
Natixis Advisors
Massachusetts
$107M +$9.96M +36,789 +10%
Goldman Sachs
41
Goldman Sachs
New York
$106M -$54M -199,506 -34%
Lazard Asset Management
42
Lazard Asset Management
New York
$105M -$26.7M -98,742 -20%
Deutsche Bank
43
Deutsche Bank
Germany
$101M +$8.52M +31,471 +9%
Alyeska Investment Group
44
Alyeska Investment Group
Illinois
$99.7M +$51.1M +188,622 +102%
Jones Financial Companies
45
Jones Financial Companies
Missouri
$96.8M +$97.5M +360,032 +5,621%
AI
46
Ariel Investments
Illinois
$94.5M -$1.64M -6,068 -2%
CS
47
CapitalatWork SA
$85.8M +$87.1M +321,710 New
Wells Fargo
48
Wells Fargo
California
$85.8M +$4.87M +17,977 +6%
EARNEST Partners
49
EARNEST Partners
Georgia
$83.5M -$2.13M -7,861 -2%
Pacer Advisors
50
Pacer Advisors
Pennsylvania
$73.9M -$9.9M -36,569 -12%

LH Hedge Fund Activity: Q1 2026 in Review

1,031 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q1 2026, worth a combined $20.9B — up 4.1% from $20B a quarter earlier.

Buyers outnumbered sellers: 109 funds opened new LH positions and 88 closed out — a net gain of 21 holders — while 336 added to existing stakes and 374 trimmed.

The largest buyer was Boston Partners, adding an estimated $123M. The largest seller was Wellington Management Group, cutting an estimated $272M.

  • 1,031 institutional investors held Labcorp (LH) as of Q1 2026, up from 1,024 in Q4 2025.
  • Funds reported $20.9B of Labcorp stock for Q1 2026, up 4.1% quarter-over-quarter.
  • 109 funds opened new Labcorp positions in Q1 2026 and 88 closed out, a net change of +21 holders.
  • The largest Labcorp buyer in Q1 2026 was Boston Partners, an estimated $123M added.
  • The largest Labcorp seller in Q1 2026 was Wellington Management Group, an estimated $272M sold.

Based on aggregated 13F filings for Q1 2026.